Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

336 Pharmacology > Exam 2- Endocrine (diabetes, steroids, thyroid) + antibiotics > Flashcards

Exam 2- Endocrine (diabetes, steroids, thyroid) + antibiotics Flashcards

1
Q

feedback loop hypoglycemia (low bg)

A

dec bg, inc glucagon metab, act gluconeogenesis, transform glycogen to glucose, inc bg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

feedback loop hyperglycemia (high bg)

A

inc bg, insulin released, glucose reuptake by skel/musc cells, dec bg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pancreas hormones

A

insulin- lowers bg, response to high bg, reuptake glucose by cells
glucagon- inc bg, reponse to low bg, releases stored glucose in form of glycogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ways to lower bg-physiologically

A

secretion insulin by pancreas
inhib gluconeogenesis
store glucose in liver as glycogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

insulin response to meals

A

responds to inc carb lvls

converts excess glucose to fat if liver stores are full (released into blood) inc risk CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

diabetes mellitus def

A

dis where body cannot produce insulin or ability to respond to the hormone insulin is impaired
= abnorm metab of carbs, inc lvl glucose in blood/urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dm manifestations- macro and micro

A

hyperglycemia (polyuria, polydipsia (thirst), polyphagia (hunger)
chronic- damages endothlium of vessels

macrovascular abnorm- inc risk CAD (heart), Stroke (Brain)
microvasc abnorm- neuropathy, kidney injury, vision changes (retinopathy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

type 1 diab

A

only respond to insulin
autoimm
pancr doesnt produce insulin
genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

type 2 diab

A

most common
cells insulin resistant
need inc insulin to transpor glucose to cells and dec bg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

insulin routes/sites

A

Iv- ONLY rapid/ shortacting
subq, injections or pumps
abdomin (fastest absorb), back arms, thighs, butt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

insulin shelf life when opened

A

1 month max at room temp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

rapid acting insulin

A

fast onset, take right b4 eating, can be mixed
for carb coverage/correction
humalong/ lispro
closest to natural response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

short acting insulin

A

fast onset, take right b4 eating, can be mixed
for carb coverage/correction
“regular”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

intermediate insulin

A 
NPH
cloudy (roll before drawing up)
long peak 6-14h
scheduled
used for basal release
can mix w/ short/rapid acting
use btw meals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

long acting insulin

A 
no mixing
1x per day
basal release
scheuled
no peak
dec risk hypoglycemia
"lantus"
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pre mixed insulin

A

70/30
70% NPH (interm)
30% reg (short)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

goals antidiabetic therapy

A 
bg normal lvl
finger stick- 70-130
a1c 4-5 but <7 acceptable
promote norm metabolism fats
prevent complications
prevent hypoglycemic episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

type 2 treatment

A

exercise, diet, oral meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

basal insulin replacement

A

use interm or long acting
set order
doses can vary from person to person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

high bg correction

A

rapid/ short acting
1unit/50 bg
formula- (acutal bg- target bg)/ correction factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

carbohydrate coverage

A

rapid/short acting
1 unit/ 15g carbs
formula- total g carbs in meal/ grams/ 1 unit
ex. 45/15= 3 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

insulin considerations- most serious side effect

A

hypoglycemia most common/serious effect
know bg prior to admin
clear before cloudy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

concious/ unconcious insulin admin

A

concisous- OJ (120mL), glucose tabs/gel
goal- 15g carb replacement

unconscious- no oral (risk aspiration), 50% dextrose IV
reassess bg 10-20min, repeat until w/in norm limits
if no iv** glucagon subq/im (20 min onset)
glycogen converted to glucose, stimulate gluconeogensis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

increased insulin requirements

A

risk for hyperglycemia

weight gain, preg, dec activity, acute infections, hypokalemia, meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

decreased insulin requirements

A

risk hypoglycemia

weight loss, dec cal intake, inc physical act, dev of renal insuff. (insulin accum bc not excreted as fast)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

antidiabetic meds- biguanides- action, indication

A

Metformin (glucophage)
action- dec intestinal absorp glucose, dec glucose production in liver, inc insulin sensitivity
indication- trt hyperglycemia assoc w/ type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

antidiabetic meds- biguanides- Metformin- route, contraindicated, pharmacokinetics

A

route- Po, taken w/ meals
pharmacokin- elim unchanged by kidneys- do not take if GFR < 30, drug can accum + become toxic
contraindicated- metabolic acidosis, radiographic studies requiring IV contrast (iodine hard enough on kid), conditions assoc w/ dec tissue perfusion (sepsis, CHF), excessive alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

antidiabetic meds- biguanides- Metformin- ae, considerations

A

ae- lactic acidosis (inc lactate lvl and dec bicarb lvl if septic- aerobic to anaerobic cellular transition creates more lactic acid)
gi distrubances, bloating, diarrh, n/v, hypoglycemia
considerations- monitor bg, renal function (cr, BUN- drug can accum), s/s lactic acidosis (chills, diarr, dizzin, hypotension, bradycardia, musc pain, dypnea, weakness)
hold med if surgery (inc risk for dec tissue perfusion= inc lactic acid) or Iv contrast
best for pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

antidiabetic meds- sulfonylureas- glucotrol or DiaBeta- action, indication and route

A

action- stim pancreatic beta cells to produce more insulin **inc risk hypoglycemia
indication- treat hypergly assoc w/ type 2
route- Po, 1x/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

antidiabetic meds- sulfonylureas- glucotrol or DiaBeta- pharmacokin, contraindicated, ae, interactions

A

pharmacokin- well absorbed/metab by liver
contraindicated- pat w/ sulfa allergy
ae- hypoglycemia, photosen, dizziness, weight gain
interactions- alcohol (disuifram (antabuse) rxn), NSAIDS, sulfa antibiotics, cimetidine (all inc action sulfonyl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

antidiabetic meds- sulfonylureas- glucotrol or DiaBeta-avoid, considerations

A

avoid- use during preg/lactation

considerationos- s/s hypoglyc, assesss bg (hold if <70), sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

antidiabetic meds- thiazolidinediones (TZDs)- Pioglitazone (actos)- action and indication, route

A

action- reduce insulin resis
indication- trt hypergly assoc w/ type2
*add on drug (not as aggressive at lowering bg)
route- Po 1x day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

antidiabetic meds- thiazolidinediones (TZDs)- Pioglitazone (actos)- pharmacokin, contraindicated

A

pharmacokin- absob/ metab by liver
contradindicated- active liver dis, active or hx bladder cancer (inc ca if taken 1+ yrs- s/s hematuria/ dysuria), CHF (inc fluid retention)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

antidiabetic meds- thiazolidinediones (TZDs)- Pioglitazone (actos)- ae, considerations

A

ae- chf, liver failure, bladder ca, hypoglycemia, fractures
considerations- monitor liver function (ast/alt)
s/s hypervol (crackles, edema, I&Os)
s/s bladder Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

antidiabetic meds- meglitinides (prandin) or Repaglinide: action, indication, route and pharmacokin

A

action- stim panc to increase secretion of insulin (same as sulfonylureas), not as likely for hypoglycemia bc has short half life
indication- hyperglycemia trtment w/ type 2
route- po, 30 min before e/ meal
pharmacokin- metab in liver, short half life 1-1.5 hrs, drug-drug interaction w/ antifungals and antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

antidiabetic meds- meglitinides (prandin) or Repaglinide: contraindicated, ae, considerations

A

contraindicated- hprsen, impaired liver fun (longer dose intervals), severe renal impairment (dec dose)
ae- hypoglycemia
considerations- monitor bg, s/s hypoglycemia, check drug interactions, assess kidney function (cr, gfr, bun)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

antidiabetic meds- alpha-glucosidase inhibitors- Acarbose (Precose): action, route, pharmacokin

A

action- delays digestion CHO (complex, sucrose, fructose) when drug and food are present in GI tract @ same time
prevents bg from increasing futher
route- po, give TID w/ 1st bite of meals
pharmacokin- metab in GI tract, some metabolites can be absorbed systemically and excreted in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

antidiabetic meds- alpha-glucosidase inhibitors- Acarbose (Precose): contraindicated, ae, considerations

A

contraindicated- pt w/ hypersen, certain GI disorders (crohns), severe renal impair
ae- hypoglycemia, Gi disturbances, abd pain, diarrhea, toots
considerations- glucose trtment not effective w/ candy or juice- drug delays absorption
need use glucose gel, tabs or IV dextrose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

antidiabetic meds- incretin mimetic (GLP-1-Agonist)- Exenatide (Byetta) action, route and pharmacokin

A

incretin- naturally occuring horm that stim pancreas to produce enough insulin for amnt of food consumed
action- pauses glucose production by the liver, slows gastric emptying
route- subq bid w/ 60 min before meals
keep refrigerated, good for 30 days
pharmacokin- excreted by kidneys (check cr, bun and gfr)
** scheduled can cause weight loss (makes ppl feel full quicker)
dec absorb cards, dec gluconeogenesis (glycogen to glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

antidiabetic meds- incretin mimetic (GLP-1-Agonist)- Exenatide (Byetta) contraindicated, ae, and considerations

A

contraindicated- end stage renal dis, hypersen, severe Gi dis, on dialysis
ae- pancreatitis, diarrh, n/v, hypoglycemia, thrombocytopenia (dec platelet count, inc risk bleeding)
considerations- dec absorp of po meds if given at same time- (give o/ meds 1hr before)
watch for s/s hypoglycemia if used w/ sulfonyurea
monitor bg, monitor for s/s pancreatitis (unexplained, persistent, severe abd pain and inc amylase)
amylase released when pancreas is inflamm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

antidiabetic meds- DPP-4 inhib- Sitagliptin (Januvia): action, route, pharmacokin

A

action- inhib DPP-4 results in inc lvls of incretin hormones
(Dpp-4 enzyme breaks dwn incretin)
indirectly inc incretin lvls (preventing incretin breakdown)
route- po daily in am (w/ or w/o food)
pharmacokin- excreted in urine unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

antidiabetic meds- DPP-4 inhib- Sitagliptin (Januvia): contraindicated, ae, and considerations

A

contraindicated- renal impairment (reduce dose)

ae- hyprsen, hypoglycemia (rare if not used w/ sulfonyrea), uppr respir infection, sore throat, headache, pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

antidiabetic meds- patient ed

A

diet, exercise and weight control!
s/s hypolycemia and trtment
1 unit / 15g CHO
use only glucose gel/ tabs for alpha glucosidase inhib (acarbose)
s/s hyperglycemia
factors effect bg- exercise, alcohol, food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

corticosteroid hormone- production

A

adrenal cortex (located above kid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

corticosteroid horm- function- cho, inflamm

A

maintain homeostasis, affect body systemically
metab of CHO, protein and lipids
inflamm and immune responses

inc corticosteroid lvls= inc gluconeogenesis (glycogen to glucose) inc bg
protein- long term use high lvls= musc wasting, thin skin
lipids- fat redistribution, buffalo hump and moon face

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

corticosteroid horm- function- body systems

A

CV- maintain bp, encourages vasoconstriction, if prolonged = htn
CNS- adeq glucose for brain
MS- dec bone formation, inc brkdwn, osteoporosis
Respir- bronchodilator and lung expansion (MDI)
GI- risk peptic ulcers, causes GI tract ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

corticosteroids- secretion and stimuli

A

controlled by HPA axis (hypothal, pituitary and adrenal cortex)
stimulated- low blood vol, stress responses (pain, anxiety, trauma, illness, infection) inc synthesis
hypothal- Corticotropin releasing horm
pituitary-adrenocortiocotropic horm
adrenal cortex- cortisol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Corticosteroid secretion negative feedback loop

A

cortisone not stopped being produced if medicated from CNS stimulation or administration of external hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

glucocorticoids

A

fun- metab, inflamm, immune processes
inc- cortiosl, corticosterone, cortisone
secreted cyclically
responsible for majority of corticosteroid effects

50
Q

mineralcorticoids

A

ex. aldosterone
maintan. flud-electrolyte balance
influences Na and H2O

51
Q

adrenal sex hormones

A

corticosteroids
androgens
estrogens and progesterone

52
Q

corticosteroid meds- glucocorticoids- actions

A

prednisone- po
methlyprenisolone- iv
dexmethasone (decadron) iv / po
fluticasone (Flonase) nasal

actions- inhib inflamm, inhib lymphocytes (immune system), strengthen/ stabilize biologic mem

53
Q

corticosteroid meds- glucocorticoids- indications for admin (use)

A 
dis of adrenal cortex (addisons)(no cortisol production)
allergic/hypersen reactions
higher doses
autoimmue dis (lupus, asthma, RA)
organ/ tissue graft or transplant
neurologic conditions (cerebral edema)
respir dis (COPD)
*trtment palliative not curative
54
Q

corticosteroid meds- glucocorticoids- contraindicated and ae

A

contraindicated- systemic fungal infections, pt w/ risk of infection, Dm (spike glucose lvls), PUD (wall destruction and vasoconstriction), HTn, CHF, renal insuff
ae- depression, euphoria, HTN, dec wound healing, fragile skin, peptic ulceration, adrenal supp, hyperglycemia, thromboembolism, osteoporosis, nausea, fluid retention, hypokalemia

55
Q

glucocortiocids- considerations

A

assess for fluid vol overload (edema, crackles, weight gain, SOB)
monitor Glucose (inc), K (dec), and WBC (dec)
assess for s/s GI bleed (dec Hbg and Hct), blood in emesis/ stool)
meds must be tapered to give HPA axis time to restart
(if not secondary adrenal insuff can happen w/ hypoten, dyspnea and weakn)

56
Q

glucocorticoids- pt ed

A

tapper off med
avoid exposure to infection
weigh frequently, monitor for fluid retention
report- sore throat, fever, s of infection, weight gain >5lb in 1 wk
dec Na intake, eat K rich foods, get adequate Ca and vitamin D for MS ae
rinse mouth w MDI
if diabetic could require extra insulin

57
Q

thyroid hormones- def and types disorders

A

t3- triiododthyroinine
t4- thyroxine
released from thyroid when gland is stim by TSH

hypo/hyperthyroidism

58
Q

thyroid horm- function

A

inc basal metab rate
inc heart rate and contractility
promote grwth/dev of children
inc lvls= tachyc

59
Q

thryoid horm flow sheet

A

hypothal- TRH, Anterior pit TSH, thryoid T3 and T4

60
Q

hypothyroidism- cause/manif

A

cause- dis destruction of thryoid gland, inadque production thryoid horm

manif- dec bp/hr, weakness, dry/thinned hair, weight gain

61
Q

hypothyroidism- types

A 
thyroiditis (can dec or inc lvls)
trtmnt w/ anithyroid drugs/ radiation therapy
secondary hypothyroidism- dec tsh or trh
congenital
adult hypothyroidism (myxedema)
62
Q

goiter cause

A

thyroid overstim by TSH- hypertrophy of thyroid gland

63
Q

thyroid horm replacement levothyroxine (synthroid)- action, indication and route

A

action- replaces/ supplem endogenous thyroid horm to normalize metab rates in tissues
indication- hypothyroidism
route- po @ breakfast 30-60 min before food (empty stomach)

64
Q

thyroid horm replacement levothyroxine (synthroid)- contraindicated, ae, considerations

A

contraindicated- hyprsen, recent MI (inc o2 demands of heart= exacerbate myocardial ischemia)
ae- iatrogenic hyperthyrodism
considerations-
food dec absorp- give 1h before breakfast
assess for s/s hyperthyroidism (tachydcardia, inc bp, chest pain, dysrhythmias)
monitor T3-4 and TSH

65
Q

relationship btw tsh and T3 and T4

A

tsh high= not enough Thyroid hormones (inc dose)

tsh low= thyroid hormones are active (dec dose)

66
Q

hyperthyroidism- cause and s/s

A

cause- graves dis (excessive t3-4)
overtrtment w/ thyroid drugs

manif- tachyca, dysrthy, exophthal, sweating

67
Q

antithyroid drugs- Propylthiouracil (PTU)- action, indication and route

A

palliative!
action- inhib production thyroid horm and conversion of t3 to active t4
indication- trtment hyperthyroidism
route- po, depends on severity

68
Q

antithyroid drugs- Propylthiouracil (PTU)- pharmacokin, ae, considerations

A

ae- agranulocytosis (dec bone marrow= dec wbc= inc risk infection)
considerations- s/s hyperthyroidism, dev of s/s hypothyroidism, WBC, thyroid function

69
Q

antithyroid drugs- sodium iodide- action, indication and route

A

action- radioactive, beta/gamma rays destroy thyroid tissue
indication- hyperthyroid
route- po, dosing specific to pt

70
Q

antithyroid drugs- sodium iodide- contraindicated, ae, considerations/ education

A

contraindicated- pregn
ae- depression hematopoietic system (blood) w/ lrg doses, n/v, tendern/ swelling in neck, sore throat, cough
ed- for 1 wk after trtment- double flush toilet, don’t touch kids, wash hands, avoid contact w/ others, stay 3 ft away and only talk for a few min, don’t share silverware, plates, cups etc

71
Q

antibiotic function

A

trt infections, not commonly used as prophylaxis (in risk resistance)

72
Q

broad spectrum v narrow spectrum

A

broad- covers gram - and +

73
Q

bactericidal

A

kill bac at therapetuic conc

74
Q

bacteriostatic

A

slowly kills bac (dec conc), allows own body’s immune system to eradicate
*not recomm for immunocomp pt

75
Q

host defense mech

A 
intact skin, muc mem
mech movements (coughing and swallowing)
immune processes (wbc and macrophages)
76
Q

opportunistic infections- complications

A

inc prevalence w/ impaired host defense
caused by outbreak norm flora
ex. c-diff, canida albicans (yeast)
complications- thrush (white tongue coating and ulcers), bacteremia

77
Q

current antibiotic trends

A

resurgence infectious dis in general
resistant strains (mrsa, vancomyacin, carpopenum)
bc over use broad spectrum and inapp prescribing (educate patient on difference btw virus and bacterial infection)

78
Q

current infectious disease trends

A

inc immunocomp pt (mre co-morbid and invasive procedures)
longer survival rates
inc pt misuse (need to take all meds as perscribed to avoid spreading resistant bac to others)

79
Q

comm aquired v nosocomial infections

A

comm- less severe, easier to trt
hospital- mre severe, difficult to trt, mostly resistant to drugs
(considered avoidable)

80
Q

causes nosocomial infections

A

mrsa (methacillin-resis staphlococcus aureus)- treated w/ penacillin originally then vancomyacin
vancomyacin resistant enterococcus- e aecalis
carbapenem resistant enterobacter
clostridium difficle
s/s distinct clor and smell, highly contageous via spores (have to wash hands w soap)
antib wipes out o/ norm flora keeping c-diff in check
high mortality rate in elderly

81
Q

prevent resistant and nosocomial infections

A

vaccinate, take cath out (urinary and central lines- jugular or subclavian)
target path (culture), treat infection not contamination (take blood cul from 2 separate sites), treat infection not colonization (>100,000= infection)
stop trtmnt when infection cured or unlikely (monitor daily)
wash hands!

82
Q

CFU

A

colony forming units
test to detect infection
<100,000= do not treat for infection
gold standard

83
Q

suspetabiliy w/ culture

A 
smaller the #= better the antib will work
bc when antib is at low does it is still effectively killing bac
x R (resistant) will not work
84
Q

penicillins-categories

A

action- bactericidal (weaken cell wall)
“bet-lactams”- antib is encapsulated in beta-lactam ring
enzymes have resist by destroying ring

85
Q

beta lactamses or penacilinases

A

enzymes secreted by bac to destroy beta lactam ring of antib

86
Q

Penacillinase sensitive- narrow spectrum

A 
PCNase sensitive ( not resistant to penicillinase bac)
gram +  (incl staph a)
PCN- G- postassium pcn G (im, iv)
procaine pcn G (im)
  cause dysrhyth if admin into blood s
benzathine pcn G (IM)

PCN V
stable in stomach acid

87
Q

PCN G and V- ae

A

min metab
excreted unchanged by kid (inc ae in pt dec renal fun)

ae- allergic rxn (monitor 1 and 2nd time when admin, verify allergy w/ pt)
nephrotoxicity (bun, cr, gfr), potassium pcn g via IV route (cause hyperkal- ventricular tachy- check renal function especially!!)

88
Q

pcnase-resistant penacillins

A 
narrow spectrum
ex. nafcillin, oxacillin, dicloxacillin
dev to preserve beta-lactam ring
popular for staph infections
inc resistance by MRSA
    therefore if pt gains resistance to pcnase-resistant it means the bac is also resistant to pcn G (and K), and pcn V
89
Q

broad spectrum penacillins- aminopcn

A

ampicillin, amoxicillin
good gram + coverage
inc gram - coverage compared to o/ narrow pcn
susceptible to penicillinases

90
Q

ampicillin v amoxicillin

A

amniopenacillins
ampicillin- po or iv
ae- rash, diarrh and pseudomembranous colitis (c-diff)

amoxicillin- po
less diarrh, rash and c-diff

b/ excreted unchanged by kidneys

91
Q

extended spectrum pcn- antipseudomonal penacillincs

A

ticarillin, piperacillin
futher inc gram neg coverage
popular- infection caused by pseudomonas aeruginosa
used in immunosupp patients

92
Q

penacillin and beta-lactamase inhib combos

A

penacillin and enzyme destroying inhibitor chem combo

amoxicillin + clavulanic acid= agumentin
ampicillin and sulbactam= Unasyn
ticarcillin and clavulanic acid= timentin
piperacillin and tazobactam = zosyn

prescribed based on pcn dose- second compound mg not vary
ex. cant use 2 500mg for 1g bc clavulanic acid dose will be x2 concentrated

93
Q

penacillins- nursing considerations

A

collect culture and blood before therapy
educate pt about completing full course
monitor wbc (effectiveness) and renal studies (toxicity, especially pcn G potassium, can be nephrotoxic)
take w/ full glass of water 1h before meal or 2h after
iv compatability- pcn not mix w/ aminoglycosides ex. gentamicin will be inactivated

94
Q

cephalosporins- diff btw generations

A

first-fourth
inc effectiveness for gram neg coverage
inc ability to cross BBB
inc penacillinase resistance (can fight ring-destroying enzyme better)

95
Q

cephalosporin- action, route, distribution and elim

A

action- bactericidal
im or iv due to poor gi absorption
distrib- 3 and 4th only reach significant conc in CSF
elim- excreted primarily unchanged in kid (except ceftriaxone or rocephin)
1/2 is by kid and 1/2 metab inactived by liver

96
Q

cephalosporin- ae

A

common- allergic rxn, mild diarrh, abd cramping, rash, pruritis (itching)
potential corss-sen w/ pcn (if pt rxn to pcn, likely will have same rxn to cephalo)
bleeding (cefoperazone, cefotetan, ceftriaxone)
hemolytic anemia (lysis rbc)
super or opportunistic infection
thrombophlebitis (diluted to dec irritation to veins)

97
Q

most common opportunistic infection

A

yeast candida of vagina or mouth

c-diff

98
Q

cephalo interactions

A 
avoid alcohol (cefazolin, cefmetazole, cefoperazone, cefotetan)
probenecid (anti gout, inc conc cephalo= inc ae)
anticoag prolong bleeding time
nephrotoxicity
99
Q

cephalosp- nursing considertions

A

may take w/ food or milk if gi irritated
monitor pt/inr, bleeding gums or easy bruising
renal (bun, cr, gfr)
liver (ast, alt) w/ certrixone

100
Q

vancomycin-action, coverage, distribution and elimination

A

bacteriocidal
gram + coverage
not beta-lactam! (no ring)= very effective against staph incl mrsa
popular for cdiff or trtmnt serious infection in pt w/ pcn allergy
poor gi absorb- admin by iv (oral if treating cdiff)- not inject IM ever
not best for treating meningitis (csf)
excreted unchanged kid- NEPHROTOX.

101
Q

vanco- ae

A

nephro
red man syndrome (act cytokines if admin too fast= rash and hypotension from vasodilation)
thrombophlebitis (dilute to dec)
thrombocytopenia (inc lysis and bleeding)

102
Q

vanco- nursing considerations

A 
monitor renal labs and TROUGH lvls
avoid nephrotoxic drugs
infuse slowly (> 60 min)
dilute solution, change infusion site often
monitor platelet count and s/s bleeding
103
Q

trough and peak lvls

A

trough- take before admin of 3rd dose
if high= inc risk nephrotoxicity

peak- take w/in 10 min of 3rd dose completion

assessed to ensure drug not accum and damaging renal cells

104
Q

tetracycline- types

A

short acting- tetracycline (8h half life)
intermediate acting- demeclocyline (12h half life)
long acting- doxycyline and minocycline (16-18h)

105
Q

tetracycline- function and use

A

broad spectrum
bacteriostatic
uses- not favored due to high resistance
chlamydia, lyme dis, h pylori (peptic ulcer) and acne

106
Q

tetracycline- pharmacokin

A

dec absorption due to food, dairy and antacids (inc affinity to Ca and Mg)
(drug binds to mol and is unabsorbable)
distribution- poor csf distrib, readily crosses placenta
elim- short/intermediate acting- kidneys
long active- liver via bile

107
Q

tetracycline- ae and considerations

A

ae-gi irritation (give w/ food), photsenitivity (sunburn easier), effects bone of infants/children (discoloration perm teeth, dec enamel dev, disruption perm teeth formation) and can alter fetal skel dev if taken during preg
prone to suprainfections
nephrotoxic
hepatoxic (long acting) monitor liver enzyme periodically

108
Q

macrolides- types

A

erthromycin
telithromycin (ketek)
azithomycin (zithromax)
clarithromycin (biaxin)

109
Q

macrolides- erythromycin- action, fun and use

A

bacteriostatic (can be bacteriocidal against highly susep organisms or in high conc)
broad spectrum (mostly gram pos. some gram neg)
enteric coated
use- respir infections (strep), skin, soft tissue, pertussis, diptheria, PID, urethritis, syphillis, rheumatic fever

110
Q

macrolides- erythromycin- pharmacokin

A

absorbp- broke dwn by gastric acid (why has enteric coating)
can be dec by food
distribution- poor csf penetration
metab- liver (cyp3a4 enzymes)- common to have d-d interactions (antib can dec absorb of o/ drug or vise versa= inc drug accum)
excretion- bile, sm amnt excreted unchanged by kidneys

111
Q

macrolides- erythromycin- ae and considerations

A

ae- gi (n/v, diarrh, epigastric pain)
CARDIOTOXIC (high conc can prolong QT interval leading to ventr tachy (torsades) and death
suprainfection
thrmbophleb w/ iv admin (dilute)

considerations- enteric-coated take w or w/o food
take w/ full glass h20
assess GI, monitor liver function tests
avoid concurrent admin of drugs that inhibit cyp3a4 enzymes (can inc effects of cardiac arrhythmias)

112
Q

Aminoglycosides- gentamicin (garamycin)

A 
ex. neomycin, kanamycin, streptomycin
very potent!
serious toxicities
bactericidal
aerobic gram neg pathogens only (need air)
113
Q

Aminoglycosides- pharmacokin

A

absorp- not absorbed in Gi (give IV only)
distributiono- poor csf pentration
crosses placenta, may be toxic to fetus
elimination- excreted unchanged in kid
(inc half life w/ dec renal function) (inc risk nephrotoxicity- check trough and peaks)

114
Q

Aminoglycosides- ae

A

ototoxicity (loss of hearing or ringing)
nephrotoxicity
neuromuscualar blockade (paralysis and musc weakness if admin fast)- trt w/ Ca infusion

115
Q

Aminoglycosides-nursing considerations

A

peak and trough
encourage fluid intake (help kid function)
monitor bun, cr, gfr, protein and urine specific gravity, I+O’s
monitor for tinnitis and muscle weakness

116
Q

sulfonamides- use, action, types

A

trimethoprim-sulfamethoxazole (TMP-SMX, Bactrim)
sulfadiazine (microsulfon)
sulfamethoxazole

bacteriostatic, broad spectrum
use- limited (resistance, less toxic options)
UTI’s especially e-coli

117
Q

sulfonamides- pharmacokin

A

absorp- well absorbed Po
distribution- good systemically, crosses placenta
metab- liver
excreted- kidneys

118
Q

sulfonamides- ae and considerations

A

ae- allergic rxn (incl stevens-johnson syndrome)= flu like s/s/ and then skin peels off (inc risk infection)
hemolytic anemia
crystalluria
photosensitivity (like tetracyclines)

assess for allergies, monitor kid fun (drug can form crystals in renal tubules bc not h20 sol)
monitor UA, CBC
pt ed- 1500-2400 (8-10) glasses water day
stop drug and call dr at first sign of rash

119
Q

Fluoroquinolones- use, func, action

A

ciprofloxacin (cipro)
levofloxacin (levaquin), enoxacin (penetrex), Lomefloxacin (maxaquin), norfloxacin (noroxin), ofloxacin (floxin)

bactericidal, broad spectrum
use- infections respir, GI, urinary, bones/joints, skin/soft tissue

120
Q

Fluoroquinolones- pharmako and ae

A

absorp- well absorbed po
distribu- low penet csf, crosses placenta
metab- liver
excretion- kidneys

black box- cartilage toxicity (rupture tendons)
worsening s of myasthenia gravis (overactive thyroid gland, musc weakness and cardiac a)
hypoglycemia coma (esp if combines w/ sulfonyrea)
psychiatric affects (inc risk depression, anxiety, confusion and hallucinations)
Gi- n/v, diarrh, abd pain
cns- dizziness
opportunitstic infections
photosen
crystalluria, acute kidney injury
121
Q

Fluoroquinolones- considerations

A

separate drug from oral antacids by 2hh
avoid use pediactric pt dt risk tendonitis/ tendon rupture
monitor for tendon pain and swelling
mon. s of bleeding if on anticoag (warfarin prolongs bleeding time)
encourage fluid intake and UV protection

336 Pharmacology (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions